Kanjinti

Product NDC
55513-141
11-digit product format
555130141
Labeler code
55513
Product ID
55513-141_94338615-f26e-4373-93ce-106894c98a87
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
trastuzumab-anns
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Labeler
Amgen, Inc
Application
BLA761073
Marketing category
BLA
Marketing start
2019-10-28
Substance
TRASTUZUMAB
Active strength
150 mg/7.15mL
Pharmacologic classes
HER2/Neu/cerbB2 Antagonists [MoA], HER2/neu Receptor Antagonist [EPC]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
Kanjinti
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
TRASTUZUMAB150 mg/7.15mL

Harmonized Identifiers#

Field, Values table
FieldValues
UniiP188ANX8CK
Rxcui2174804, 2174809, 2257297, 2257300

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
bd11614e-4776-4a92-aaca-2bcbb5f710edProduct name120210115
b914e981-d6dc-4748-bd51-accd6b85b817Product name120190618
9397f6d4-17a1-42b4-beda-fa2c0ea40c8cProduct name120190610
0ca1d589-929b-4b33-bc5b-1d84abdafa6aProduct name120150324
fc363c46-397b-4476-ac0f-70e43e8e4592Product name120150324

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
55513-141-01Kanjinti7.15 mL in 1 VIAL, SINGLE-DOSEINJECTION, POWDER, LYOPHILIZED,7.1522
55513-141-01Kanjinti1 in 1 CARTONINJECTION, POWDER, LYOPHILIZED,122
55513-141-21Kanjinti1 in 1 CARTONINJECTION, POWDER, LYOPHILIZED,122
55513-141-21Kanjinti7.15 mL in 1 VIAL, SINGLE-DOSEINJECTION, POWDER, LYOPHILIZED,7.1522

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
55513-141-01EA - Each55513-141ea2274e0-e3f0-412a-a890-36ca6bd3d40812019-11-12
55513-141-21EA - Each55513-1419bf6ac63-161f-42cd-b43e-e579ee8c812612025-12-16

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
55513-141KANJINTI (TRASTUZUMAB-ANNS) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION KANJINTI (TRASTUZUMAB-ANNS) KIT [AMGEN INC]19Current NDC, Legacy NDC, 4 package rows20250205_9a94f5b2-b84e-4987-8ea1-c4346db5a5fa.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
2257300KANJINTI 150 MG InjectionPSN9a94f5b2-b84e-4987-8ea1-c4346db5a5fa22
2174809KANJINTI 420 MG in 20 mL Injectable SolutionPSN9a94f5b2-b84e-4987-8ea1-c4346db5a5fa22
2257297trastuzumab-anns 150 MG InjectionPSN9a94f5b2-b84e-4987-8ea1-c4346db5a5fa22
2174804trastuzumab-anns 420 MG in 20 mL Injectable SolutionPSN9a94f5b2-b84e-4987-8ea1-c4346db5a5fa22
2257300trastuzumab-anns 150 MG Injection [Kanjinti]SBD9a94f5b2-b84e-4987-8ea1-c4346db5a5fa22
2174809trastuzumab-anns 21 MG/ML Injectable Solution [Kanjinti]SBD9a94f5b2-b84e-4987-8ea1-c4346db5a5fa22
2257297trastuzumab-anns 150 MG InjectionSCD9a94f5b2-b84e-4987-8ea1-c4346db5a5fa22
2174804trastuzumab-anns 21 MG/ML Injectable SolutionSCD9a94f5b2-b84e-4987-8ea1-c4346db5a5fa22
2257300Kanjinti 150 MG InjectionSY9a94f5b2-b84e-4987-8ea1-c4346db5a5fa22
2174809Kanjinti 21 MG/ML Injectable SolutionSY9a94f5b2-b84e-4987-8ea1-c4346db5a5fa22
2174809Kanjinti 420 MG per 20 ML Injectable SolutionSY9a94f5b2-b84e-4987-8ea1-c4346db5a5fa22
2174804trastuzumab-anns 420 MG per 20 ML Injectable SolutionSY9a94f5b2-b84e-4987-8ea1-c4346db5a5fa22

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
55513-141-01555130141011 VIAL, SINGLE-DOSE in 1 CARTON (55513-141-01) / 7.15 mL in 1 VIAL, SINGLE-DOSE2019-10-280000-00-00NoNoCurrent
55513-141-21555130141211 VIAL, SINGLE-DOSE in 1 CARTON (55513-141-21) / 7.15 mL in 1 VIAL, SINGLE-DOSE2025-07-01NoNoHistorical